Recent Advancement in Ocular Drug Delivery System: A Systematic Review

Chavi Mittal; Vandana Sonaji Amle; Roshan Kumar; Prachi Sood; Archna Uniyal; Harjeet Singh

doi:10.55544/jrasb.2.3.32

Authors

Chavi Mittal Assistant Professor, Department of Pharmaceutics, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.
Vandana Sonaji Amle Assistant Professor, Swami Ramanand Teerth Marathwada University Nanded- 431606, Maharashtra, INDIA.
Roshan Kumar Assistant Professor, Department of Pharmacology, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.
Prachi Sood Assistant Professor, Department of Pharmacy, Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.
Archna Uniyal Associate Professor, Shree Dev Bhoomi Institute of Science and Technology, Dehradun, Uttarakhand, INDIA.
Harjeet Singh Guru Nanak College of Pharmaceutical Sciences, Dehradun-248007, Uttarakhand, INDIA.

DOI:

https://doi.org/10.55544/jrasb.2.3.32

Keywords:

ODDS, Chitson, nanotechnology, Drug therapy

Abstract

Recent scientific and technological advancements have made ophthalmology a top priority for the study of therapeutic products, including the creation, preclinical testing, and clinical evaluation of novel medications, medical devices, and drug-medical device combinations. In order to decrease metabolism and elimination and increase residence time in ocular tissues and compartments, sustained-release drug delivery systems such as liposomes, micelles, nano-emulsions, nanoparticles with colloidal structures, and intraocular implants have been developed. Research is also being conducted in the area of cutting-edge medicines, including those based on gene or cell systems, both of which are considered high-risk products because to their intricate structures. Regarding the definition of drug (medicinal product) and recent changes in regulation, this article reviews recent advancements in ophthalmic drug, gene, and cellular delivery systems and related goods as well as breakthroughs in advanced therapeutic medicinal Products.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018). Advances in biomaterials for drug delivery. Advanced Materials, 30(29), 1705328.

Dhiman, N., Awasthi, R., Sharma, B., Kharkwal, H., & Kulkarni, G. T. (2021). Lipid nanoparticles as carriers for bioactive delivery. Frontiers in chemistry, 9, 580118.

Lerch, M. M., Hansen, M. J., van Dam, G. M., Szymanski, W., & Feringa, B. L. (2016). Emerging targets in photopharmacology. Angewandte Chemie International Edition, 55(37), 10978-10999.

Khosa, A., Reddi, S., & Saha, R. N. (2018). Nanostructured lipid carriers for site-specific drug delivery. Biomedicine & Pharmacotherapy, 103, 598-613.

Varela-Fernández, R., Díaz-Tomé, V., Luaces-Rodríguez, A., Conde-Penedo, A., García-Otero, X., Luzardo-Álvarez, A., ... & Otero-Espinar, F. J. (2020). Drug delivery to the posterior segment of the eye: Biopharmaceutic and pharmacokinetic considerations. Pharmaceutics, 12(3), 269.

Zennifer, A., Senthilvelan, P., Sethuraman, S., & Sundaramurthi, D. (2021). Key advances of carboxymethyl cellulose in tissue engineering & 3D bioprinting applications. Carbohydrate Polymers, 256, 117561.

Tran, L., Xiao, J. F., Agarwal, N., Duex, J. E., & Theodorescu, D. (2021). Advances in bladder cancer biology and therapy. Nature Reviews Cancer, 21(2), 104-121.

Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. (2020). Polymeric nanoparticles for drug delivery: Recent developments and future prospects. Nanomaterials, 10(7), 1403.

Gedde, S. J., Vinod, K., Wright, M. M., Muir, K. W., Lind, J. T., Chen, P. P., ... & Mansberger, S. L. (2021). Primary open-angle glaucoma preferred practice pattern®. Ophthalmology, 128(1), P71-P150.

Li, W., Tang, J., Lee, D., Tice, T. R., Schwendeman, S. P., & Prausnitz, M. R. (2022). Clinical translation of long-acting drug delivery formulations. Nature Reviews Materials, 7(5), 406-420.

Zhang, X., Wei, D., Xu, Y., & Zhu, Q. (2021). Hyaluronic acid in ocular drug delivery. Carbohydrate Polymers, 264, 118006.

Peng, C., Kuang, L., Zhao, J., Ross, A. E., Wang, Z., & Ciolino, J. B. (2022). Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020. Journal of Controlled Release, 345, 625-645.

Gupta, B., Mishra, V., Gharat, S., Momin, M., & Omri, A. (2021). Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems. Pharmaceuticals, 14(11), 1201.

Marchesi, N., Fahmideh, F., Boschi, F., Pascale, A., & Barbieri, A. (2021). Ocular neurodegenerative diseases: interconnection between retina and cortical areas. Cells, 10(9), 2394.

Mohamed, H. B., Abd El-Hamid, B. N., Fathalla, D., & Fouad, E. A. (2022). Current trends in pharmaceutical treatment of dry eye disease: A review. European Journal of Pharmaceutical Sciences, 175, 106206.

Lin, P. H., Jian, H. J., Li, Y. J., Huang, Y. F., Anand, A., Huang, C. C., ... & Lai, J. Y. (2022). Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels. Acta Biomaterialia, 141, 140-150.

Ye, J., Fu, S., Zhou, S., Li, M., Li, K., Sun, W., & Zhai, Y. (2020). Advances in hydrogels based on dynamic covalent bonding and prospects for its biomedical application. European Polymer Journal, 139, 110024.

Melo, G. B., da Cruz, N. F. S., Emerson, G. G., Rezende, F. A., Meyer, C. H., Uchiyama, S., ... & Rodrigues, E. B. (2021). Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections. Progress in Retinal and Eye Research, 80, 100862.

Kumar, R., Saha, P., Kahwa, I., Boateng, E. A., Boateng, P. O., & Nyarko, R. O. (2022). Biological Mode of Action of Phospholipase A and the Signalling and Pro and Anti Inflammatory Cytokines: A Review. Journal of Advances in Medicine and Medical Research, 34(9), 1-10.

Keshri, S., Kumar, R., Kumar, D., Singhal, T., Giri, S., Sharma, I., & Vatsha, P. (2022). Insights Of Artificial Intelligence In Brain Disorder With Evidence Of Opportunity And Future Challenges. Journal of Pharmaceutical Negative Results, 10853-10867.

Bist, V. L., & Faruk, A. (2023). Recent Advancement in Self Emulsifing Drug Delivery System. Journal for Research in Applied Sciences and Biotechnology, 2(2), 89-101.

Shukla, S., Rawat, N., Rana, S., Rana, V., Mittal, C., Kumar, R., & Sood, P. (2023). Clinical Features Present, Past & Future Prospective of Monkey Pox: A Orthopoxvirus. Journal for Research in Applied Sciences and Biotechnology, 2(3), 134-146.

Kumar, A., Uniyal, Y., & Kumar, R. (2022). Recent Advancement of Colorectal Cancer and Their Herbal Essential Oil Treatment. Journal for Research in Applied Sciences and Biotechnology, 1(5), 133-144.

Kohli, A., & Kumar, R. (2023). Role of Antioxidants of Natural Herbs in Management of Male Infertility. Journal for Research in Applied Sciences and Biotechnology, 2(1), 55-80.

Butola, K., Bisht, V., & Kumar, R. (2023). Recent Approaches of Ocular Disease and Its Herbal Product Treatment: An Updates. Journal for Research in Applied Sciences and Biotechnology, 2(2), 102-114.

Mazet, R., Yaméogo, J. B., Wouessidjewe, D., Choisnard, L., & Gèze, A. (2020). Recent advances in the design of topical ophthalmic delivery systems in the treatment of ocular surface inflammation and their biopharmaceutical evaluation. Pharmaceutics, 12(6), 570.

Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., ... & Kommineni, N. (2023). Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications. Pharmaceutics, 15(4), 1313.

Attia, S. A., & MacKay, J. A. (2022). Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews, 114441.

Cheng, K. J., Hsieh, C. M., Nepali, K., & Liou, J. P. (2020). Ocular disease therapeutics: design and delivery of drugs for diseases of the eye. Journal of Medicinal Chemistry, 63(19), 10533-10593.

Amador, C., Shah, R., Ghiam, S., Kramerov, A. A., & Ljubimov, A. V. (2022). Gene therapy in the anterior eye segment. Current gene therapy, 22(2), 104.

Cheng, K. J., Hsieh, C. M., Nepali, K., & Liou, J. P. (2020). Ocular disease therapeutics: design and delivery of drugs for diseases of the eye. Journal of Medicinal Chemistry, 63(19), 10533-10593.

Attia, S. A., & MacKay, J. A. (2022). Protein and polypeptide mediated delivery to the eye. Advanced Drug Delivery Reviews, 114441.

Chatterjee, S., Upadhyay, P., Mishra, M., Srividya, M., Akshara, M. R., Kamali, N., ... & Misra, S. K. (2020). Advances in chemistry and composition of soft materials for drug releasing contact lenses. Rsc Advances, 10(60), 36751-36777.

Sun, X., Sheng, Y., Li, K., Sai, S., Feng, J., Li, Y., ... & Tian, B. (2022). Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: Synthesis, in vitro/vivo evaluation, and mechanism. Acta Biomaterialia, 138, 193-207.

Ryu, J. (2022). New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics. International Journal of Molecular Sciences, 23(15), 8529.

Fan, X., Torres-Luna, C., Azadi, M., Domszy, R., Hu, N., Yang, A., & David, A. E. (2020). Evaluation of commercial soft contact lenses for ocular drug delivery: A review. Acta Biomaterialia, 115, 60-74.

Qiao, H., Xu, Z., Sun, M., Fu, S., Zhao, F., Wang, D., ... & Sun, J. (2022). Rebamipide liposome as an effective ocular delivery system for the management of dry eye disease. Journal of Drug Delivery Science and Technology, 75, 103654.

Tian, B., Bilsbury, E., Doherty, S., Teebagy, S., Wood, E., Su, W., ... & Lin, H. (2022). Ocular drug delivery: advancements and Innovations. Pharmaceutics, 14(9), 1931.

Shekhar, S., Kumar, A., Rana, V., Kumar, R., Mittal, C., & Tariyal, K. (2023). Recent Approaches of Matrix Release Tablet in NDDS System. Journal for Research in Applied Sciences and Biotechnology, 2(3), 64-71.

Kumar, R., Sood, P., Rana, V., & Prajapati, A. K. (2023). Combine Therapy of Gallic Acid and Allicin in Management of Diabetes. Journal for Research in Applied Sciences and Biotechnology, 2(3), 91-99.

Kumar, R., & Saha, P. (2022). A review on artificial intelligence and machine learning to improve cancer management and drug discovery. International Journal for Research in Applied Sciences and Biotechnology, 9(3), 149-156.

Amle, V. S., Rathod, D. A., Keshamma, E., Kumar, V., Kumar, R., & Saha, P. (2022). Bioactive Herbal Medicine Use for Eye Sight: A Meta Analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 42-50.

Kumar, R., Saha, P., Keshamma, E., Sachitanadam, P., & Subramanian, M. (2022). Docking studies of some novel Hetrocyclic compound as Acat inhibitors: A meta analysis. Journal for Research in Applied Sciences and Biotechnology, 1(3), 33-41.

Subramanian, M., Keshamma, E., Janjua, D., Kumar, D., Kumar, R., Saha, P., ... & Rao, S. (2022). Quality risk management approach for drug development and its future prospectives. Journal for Research in Applied Sciences and Biotechnology, 1(3), 166-177.

Patel, R. K., Gangwar, D., Gupta, H., Sharma, N., & Kumar, R. (2023). Plants Alkaloids Based Compound as Therapeutic Potential for Neurodegenerative. Journal for Research in Applied Sciences and Biotechnology, 2(2), 14-26.

Kashyap, N., Kumar, R., Rana, V., Sood, P., & Chauhan, T. (2023). Role of Terpenoids Active Ingredients Targeting for Neuroprotective Agents. Journal for Research in Applied Sciences and Biotechnology, 2(3), 22-40.

Gadziński, P., Froelich, A., Wojtyłko, M., Białek, A., Krysztofiak, J., & Osmałek, T. (2022). Microneedle-based ocular drug delivery systems–recent advances and challenges. Beilstein Journal of Nanotechnology, 13(1), 1167-1184.

Gote, V., Ansong, M., & Pal, D. (2020). Prodrugs and nanomicelles to overcome ocular barriers for drug penetration. Expert Opinion on Drug Metabolism & Toxicology, 16(10), 885-906.

Berillo, D., Zharkinbekov, Z., Kim, Y., Raziyeva, K., Temirkhanova, K., & Saparov, A. (2021). Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery. Pharmaceutics, 13(12), 2050.

Arribada, R. G., Behar-Cohen, F., de Barros, A. L. B., & Silva-Cunha, A. (2022). The use of polymer blends in the treatment of ocular diseases. Pharmaceutics, 14(7), 1431.

Almehmady, A. M., El-Say, K. M., Mubarak, M. A., Alghamdi, H. A., Somali, N. A., Sirwi, A., ... & Ahmed, T. A. (2022). Enhancing the antifungal activity and ophthalmic transport of fluconazole from PEGylated polycaprolactone loaded nanoparticles. Polymers, 15(1), 209.

Kanaan, A. F., Piedade, A. P., de Sousa, H. C., & Dias, A. M. (2021). Semi-interpenetrating chitosan/ionic liquid polymer networks as electro-responsive biomaterials for potential wound dressings and iontophoretic applications. Materials Science and Engineering: C, 121, 111798.

Wroblewska, K. B., Jadach, B., & Muszalska-Kolos, I. (2021). Progress in drug formulation design and delivery of medicinal substances used in ophthalmology. International Journal of Pharmaceutics, 607, 121012.

Mobaraki, M., Soltani, M., Zare Harofte, S., L. Zoudani, E., Daliri, R., Aghamirsalim, M., & Raahemifar, K. (2020). Biodegradable nanoparticle for cornea drug delivery: Focus review. Pharmaceutics, 12(12), 1232.

Rebibo, L., Frušić-Zlotkin, M., Ofri, R., Nassar, T., & Benita, S. (2022). The dose-dependent effect of a stabilized cannabidiol nanoemulsion on ocular surface inflammation and intraocular pressure. International Journal of Pharmaceutics, 617, 121627.

Sharma, D. S., Wadhwa, S., Gulati, M., Kadukkattil Ramanunny, A., Awasthi, A., Singh, S. K., ... & Vishwas, S. (2021). Recent advances in intraocular and novel drug delivery systems for the treatment of diabetic retinopathy. Expert Opinion on Drug Delivery, 18(5), 553-576.

Maccarone, R., Tisi, A., Passacantando, M., & Ciancaglini, M. (2020). Ophthalmic applications of cerium oxide nanoparticles. Journal of Ocular Pharmacology and Therapeutics, 36(6), 376-383.

Kesav, N. P., Young, C. E. C., Ertel, M. K., Seibold, L. K., & Kahook, M. Y. (2021). Sustained-release drug delivery systems for the treatment of glaucoma. International Journal of Ophthalmology, 14(1), 148.

O’Brien Laramy, M. N., & Nagapudi, K. (2022). Long-acting ocular drug delivery technologies with clinical precedent. Expert Opinion on Drug Delivery, 19(10), 1285-1301.

Navarro-Partida, J., Castro-Castaneda, C. R., Santa Cruz-Pavlovich, F. J., Aceves-Franco, L. A., Guy, T. O., & Santos, A. (2021). Lipid-based nanocarriers as topical drug delivery systems for intraocular diseases. Pharmaceutics, 13(5), 678.

Gedde, S. J., Lind, J. T., Wright, M. M., Chen, P. P., Muir, K. W., Vinod, K., ... & Mansberger, S. L. (2021). Primary open-angle glaucoma suspect preferred practice pattern®. Ophthalmology, 128(1), P151-P192.

Yang, C., Yang, J., Lu, A., Gong, J., Yang, Y., Lin, X., ... & Xu, H. (2022). Nanoparticles in ocular applications and their potential toxicity. Frontiers in Molecular Biosciences, 9, 931759.

Kulkarni, M. B., Velmurugan, K., Prasanth, E., Amreen, K., Nirmal, J., & Goel, S. (2021). Smartphone enabled miniaturized temperature controller platform to synthesize nio/cuo nanoparticles for electrochemical sensing and nanomicelles for ocular drug delivery applications. Biomedical Microdevices, 23, 1-13.

Taka, E., Karavasili, C., Bouropoulos, N., Moschakis, T., Andreadis, D. D., Zacharis, C. K., & Fatouros, D. G. (2020). Ocular co-delivery of timolol and brimonidine from a self-assembling peptide hydrogel for the treatment of glaucoma: In vitro and ex vivo evaluation. Pharmaceuticals, 13(6), 126.

Gedde, S. J., Lind, J. T., Wright, M. M., Chen, P. P., Muir, K. W., Vinod, K., ... & Mansberger, S. L. (2021). Primary open-angle glaucoma suspect preferred practice pattern®. Ophthalmology, 128(1), P151-P192.

Shah, S., Bhanderi, B., Soniwala, M., & Chavda, J. (2021). Lutein-Loaded solid lipid nanoparticles for ocular delivery: Statistical optimization and ex vivo evaluation. Journal of Pharmaceutical Innovation, 1-15.

Gugleva, V., & Andonova, V. (2023). Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms. Pharmaceuticals, 16(3), 474.

Umama, Y., Venkatajah, G., Shourabh, R., Kumar, R., Verma, A., Kumar, A., & Gayoor, M. K. (2019). Topic-The scenario of pharmaceuticals and development of microwave as; sisted extraction technique. World J Pharm Pharm Sci, 8(7), 1260-1271.

Nyarko, R. O., Roopini, R., Raviteja, V., Awuchi, C. G., Kumar, R., Faller, E. M., ... & Saha, P. (2022). Novel Sars-CoV-2 Variants & Therapeutic Effects. Journal for Research in Applied Sciences and Biotechnology, 1(2), 25-34.

Sultana, A., Singh, M., Kumar, A., Kumar, R., Saha, P., Kumar, R. S., & Kumar, D. (2022). To identify drug-drug interaction in cardiac patients in tertiary care hospitals. Journal for Research in Applied Sciences and Biotechnology, 1(3), 146-152.

Nyarko, R. O., Awuchi, C. G., Kumar, R., Boateng, E., Kahwa, I., Boateng, P. O., ... & Saha, P. (2022). Evaluation of cafeteria diet in experimental animal with plant extract of calotropis procera for obesity parameter. Journal for Research in Applied Sciences and Biotechnology, 1(3), 107-113.

Prajapati, A. K., Sagar, S., & Kumar, R. (2022). Past and Current Prospectives of Herbal Product for Skin Care. Journal for Research in Applied Sciences and Biotechnology, 1(5), 145-160.

Awuchi, C. G., Saha, P., Amle, V. S., Nyarko, R. O., Kumar, R., Boateng, E. A., ... & Asum, C. (2023). A Study of Various Medicinal Plants used in Ulcer Treatment: A Review. Journal for Research in Applied Sciences and Biotechnology, 2(1), 234-246.

Gedde, S. J., Lind, J. T., Wright, M. M., Chen, P. P., Muir, K. W., Vinod, K., ... & Mansberger, S. L. (2021). Primary open-angle glaucoma suspect preferred practice pattern®. Ophthalmology, 128(1), P151-P192.

World Health Organization. World Report on Vision; World Health Organization: Geneva, Switzerland, 2019; ISBN 9789241516570.

Usgaonkar, U.; Shet Parkar, S.R.; Shetty, A. Impact of the use of digital devices on eyes during the lockdown period of COVID-19 pandemic. Ind. J. Ophthalmol. 2021, 69, 1901–1906. [

Shalini, S.; Ipsita, P.; Abhay, P.; Pandey, A.K. Life style disorders in ophthalmology and their management. Environ. Conserv. J. 2019, 20, 67–72.

García-Marqués, J.V.; Talens-Estarelles, C.; García-Lázaro, S.; Wolffsohn, J.S.; Cerviño, A. Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population. Cont. Lens Anterior Eye. 2022, 45, 101539.

Bourne, R.R.A.; Steinmetz, J.D.; Flaxman, S.; Briant, P.S.; Taylor, H.R.; Resnikoff, S.; Casson, R.J.; Abdoli, A.; Gharbieh, E.A.; Afshin, A.; et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study. Lancet Glob. Health. 2021, 9, e130–e143.

Gote, V.; Sikder, S.; Sicotte, J.; Pal, D. Ocular Drug Delivery: Present Innovations and Future Challenges. J. Pharmacol. Exp. Ther. 2019, 370, 602–624.

Patel, A.; Cholkar, K.; Agrahari, V.; Mitra, A.K. Ocular drug delivery systems: An overview. World J. Pharmacol. 2013, 2, 47–64.

Nayak, K.; Misra, M. A review on recent drug delivery systems for posterior segment of eye. Biomed. Pharmacother. 2018, 107, 1564–1582.

Bachu, R.D.; Chowdhury, P.; Al-Saedi, Z.H.F.; Karla, P.K.; Boddu, S.H.S. Ocular Drug Delivery Barriers-Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics 2018, 10, 28.

Wilson, C.G. Ophthalmic Formulation. In Specialized Pharmaceutical Formulation: The Science and Technology of Dosage Forms, 1st ed.; Tovey, G.D., Ed.; Royal Society of Chemistry: London, UK, 2022; pp. 1–44.

Kuno, N.; Fujii, S. Recent Advances in Ocular Drug Delivery Systems. Polymers 2011, 3, 193–221.

Jünemann, A.G.M.; Chorągiewicz, T.; Ozimek, M.; Grieb, P.; Rejdak, R. Drug bioavailability from topically applied ocular drops. Does drop size matter? Ophthalmol. J. 2016, 1, 29–35.

Taghe, S.; Mirzaeei, S. Preparation and characterization of novel, mucoadhesive ofloxacin nanoparticles for ocular drug delivery. Braz. J. Pharm. Sci. 2019, 55, e17105.

Gaudana, R.; Ananthula, H.K.; Parenky, A.; Mitra, A.K. Ocular drug delivery. AAPS J. 2010, 12, 348–360.

Baranowski, P.; Karolewicz, B.; Gajda, M.; Pluta, J. Ophthalmic drug dosage forms: Characterisation and research methods. Sci. World J. 2014, 2014, 861904.

Wu, Y.; Liu, Y.; Li, X.; Kebebe, D.; Zhang, B.; Ren, J.; Lu, J.; Li, J.; Du, S.; Liu, Z. Research progress of in-situ gelling ophthalmic drug delivery system. Asian J. Pharm. Sci. 2019, 14, 1–15.

Bastawrous, A.; Burgess, P.I.; Mahdi, A.M.; Kyari, F.; Burton, M.J.; Kuper, H. Posterior segment eye disease in sub-Saharan Africa: Review of recent population-based studies. Trop. Med. Int. Health. 2014, 19, 600–609

Tóth, G.; Szabó, D.; Sándor, G.L.; Nagy, Z.Z.; Limburg, H.; Németh, J. Hátsószegmens-betegségek okozta látásromlás és vakság Magyarországon az 50 évnél idosebb korú lakosság körében [Visual impairment and blindness caused by posterior segment diseases in Hungary in people aged 50 years and older]. Orv. Hetil. 2022, 163, 624–630.

Varela-Fernández, R.; Díaz-Tomé, V.; Luaces-Rodríguez, A.; Conde-Penedo, A.; García-Otero, X.; Luzardo-Álvarez, A.; Fernández-Ferreiro, A.; Otero-Espinar, F.J. Drug Delivery to the Posterior Segment of the Eye: Biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics 2020, 12, 269.

Otero-Espinar, F.J.; Fernández-Ferreiro, A.; González-Barcia, M.; Blanco-Méndez, J.; Luzardo, A. Stimuli sensitive ocular drug delivery systems. In Drug Targeting and Stimuli Sensitive Drug Delivery Systems, 1st ed.; Grumezescu, A., Ed.; Elsevier: Amsterdam, The Netherlands, 2018; pp. 211–270.

Sánchez-López, E.; Espina, M.; Doktorovova, S.; Souto, E.B.; García, M.L. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye—Part I—Barriers and determining factors in ocular delivery. Eur. J. Pharm. Biopharm. 2017, 110, 70–75.

Sun, L.; Zhang, M.; Shi, Y.; Fang, L.; Cao, F. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater. 2022, 141, 164–177.

Xu, X.; Sun, L.; Zhou, L.; Cheng, Y.; Cao, F. Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone. Carbohydr. Polym. 2020, 227, 115356

Nayak, K.; Misra, M. PEGylated microemulsion for dexamethasone delivery to posterior segment of eye. J. Biomater. Sci. Polym. Ed. 2020, 31, 1071–1090.

Bachu, R.D.; Stepanski, M.; Alzhrani, R.M.; Jung, R.; Boddu, S.H.S. Development and Evaluation of a Novel Microemulsion of Dexamethasone and Tobramycin for Topical Ocular Administration. J. Ocul. Pharmacol. Ther. 2018, 34, 312–324.

Bravo-Osuna, I.; Vicario-de-la-Torre, M.; Andrés-Guerrero, V.; Sánchez-Nieves, J.; Guzmán-Navarro, M.; de la Mata, F.J.; Gómez, R.; de Las Heras, B.; Argüeso, P.; Ponchel, G.; et al. Novel Water-Soluble Mucoadhesive Carbosilane Dendrimers for Ocular Administration. Mol. Pharm. 2016, 13, 2966–2976.

Ghasemiyeh, P.; Mohammadi-Samani, S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: Applications, advantages and disadvantages. Res. Pharm. Sci. 2018, 13, 288–303.

Costa, C.P.; Barreiro, S.; Moreira, J.N.; Silva, R.; Almeida, H.; Sousa Lobo, J.M.; Silva, A.C. In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals 2021, 14, 711.